HIV Vaccine Studies

The Status of Preventative HIV Vaccine Research

HIV vaccine development continues around the world. But as we all know, the road to a working, effective HIV vaccine is littered with barriers and road blocks.

The Barriers to Vaccine Development

This feature gives you an update on many of the HIV vaccine research trials being conducted today. Specifically, the following HIV vaccine trials are studies for preventative HIV vaccines; those vaccines that would be given to HIV negative people to prevent HIV infection.

Preventative HIV Vaccines - Status

• ALVAC-HIV vCP1452 Alone and Combined with MN rgp120
  Conditions: HIV Infections; HIV Negative
  Status: Ongoing but not recruiting at this time.

• HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
  Conditions: HIV Infections; HIV Negative
  Status: Ongoing but not recruiting at this time.

• A Study to Prepare for Future HIV Vaccine Studies
  Conditions: HIV Infections
  Status: Ongoing but not recruiting at this time.

• Safety of an HIV DNA Vaccine Given to HIV-Uninfected Adults
  Conditions: HIV Infections
  Status: This study has been completed.

• Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults
  Conditions: HIV Infections
  Status: This study has been completed.

• Screening Protocol for HIV Vaccine Studies
  Conditions: HIV Infections; HIV Negative
  Status: This study is recruiting subjects at this time.

• HIV-1 Vaccine Test in Uninfected Adult Volunteers
  Conditions: Healthy
  Status: This study has been completed.

• HIV-1 Vaccine Test in Uninfected Adult Volunteers
  Conditions: Healthy; HIV Negative
  Status: This study has been completed.

_{Source: US National Institutes of Health; "ClinicalTrials.gov"; 17 Jan 2007.}